Viewing Study NCT00833560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-07-02 @ 11:52 PM
Study NCT ID: NCT00833560
Status: COMPLETED
Last Update Posted: 2014-11-21
First Post: 2009-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
Sponsor: Janssen-Cilag G.m.b.H
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None Untreated multiple myeloma View
None Bortezomib View
None VELCADE View
None Cyclophosphamide View
None Dexamethasone View
None Chemotherapy View
None Remission therapy View
None Induction therapy View
None Stem Cell Transplantation View